Addressing the Challenges of Next-Generation Antibody-Drug Conjugate Medicines

Access and leverage deep industry knowledge into some of the key strategies in support appropriate target product profiling for the development of next-generation antibody-drug conjugates (ADCs).

You May Also be Interested in